On Friday, Enova International got an upgrade for its IBD SmartSelect Composite Rating from 94 to 96.
Discover The 3 Keys To Successful Stock Investing
The new score tells you the company is now outperforming 96% of all stocks in terms of the most important fundamental and technical stock-picking criteria. History shows the top market performers tend to have a 95 or higher score as they launch their major climbs.
Enova International is not currently near a proper buy zone. Look for the stock to form and break out of a new base.
The stock earns a 93 EPS Rating, meaning its recent quarterly and longer-term annual earnings growth is outpacing 93% of all stocks.
Its Accumulation/Distribution Rating of C shows a roughly equal amount of buying and selling by institutional investors over the last 13 weeks.
In Q1, the company posted 56% earnings growth. Revenue growth fell to 22%, down from 25% in the prior quarter.
Enova International holds the No. 2 rank among its peers in the Finance-Consumer Loans industry group. Atlanticus Holdings is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
